RxDoctor Payments Data

Mark Kazewych, MD

Orthopaedic Surgery · Arlington, TXNPI 1063452944

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.2%. Reporting peaked in 2019 at $3,306 and has fallen 68.1% since, to $1,056 in 2025.

$11,382in general payments, 2019–2025

Across 148 payments — averaging $76.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Anika Therapeutics, Inc.$2K
  • Advanced Orthopaedic Solutions, Inc.$2K
  • Pylant Medical$1K
  • Vericel Corporation$766
  • Amgen$547
  • plus $2K from 16 others
$65,147in research payments, 2019–2025

Across 10 payments — averaging $6514.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$47K
  • Smith+Nephew$18K
$816,901in ownership & investment interests, 2019–2025

Across 7 payments — averaging $116,700 each. An ownership or investment interest held by the physician or an immediate family member.

  • 4web, Inc.$817K

What the payments were for

  • Consulting fees$2,22520%
  • Travel & lodging$2,00518%
  • Food & beverage$5,95252%
  • Education$1,20011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,382 in reported general payments places this provider in the 70th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$134,103
Medicare patients
298
Services billed
1,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib121$1,142
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen82$793
Meloxicam167$412
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$326
Ondansetron Hcl35$132
Gabapentin12$117
Amoxicillin49$46

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →